StockNews.AI
ENGN
StockNews.AI
140 days

enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum

1. ENGN's CEO will present at the Stifel 2025 Oncology Forum. 2. The presentation may attract investor interest in ENGN's genetic medicine innovations.

2m saved
Insight
Article

FAQ

Why Bullish?

The CEO's presentation could spotlight ENGN’s advancements, similar to past successful investor events boosting stock appreciation.

How important is it?

The presentation at a significant forum could enhance marketplace confidence and interest in ENGN.

Why Short Term?

Investor interest may spike immediately following the event due to heightened visibility.

Related Companies

CRISAVXLEDIT
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, Chief Executive Officer, will present at the Stifel 2025 Virtual Targeted Oncology Forum, on Tuesday, April 8, 2025, at 4:00 p.m. ET. A live webcast of the presentation can be accessed under the “Investors” section of the enGene website at www.engene.com and will be archived there for 90 days. About enGene e.

Related News